DrugsControl Media Services

News Detail

AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19 (11-10-2021)

Cambridge, 11 Oct 2021: AstraZeneca's experimental Covid-19 antibody drug cocktail succeeded in reducing severe disease or death in non-hospitalised patients in a late-stage study, the British drugmaker said on Monday.

The drug, called AZD7442, reduced the risk of d......
View Details

Source : The Times of India

Related News